Hai-Liang Zhang (Hailiang Zhang)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

High Resolution

Dna Damage Response

Top Venues

Nature communications

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Wen-Hao Xu, Jiahe Lu, Xi Tian, Shiqi Ye, Shiyin Wei, Jun Wang, Aihetaimujiang Anwaier, Yuanyuan Qu, Wang-Rui Liu, Kun Chang, Hai-Liang Zhang, Dingwei Ye
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. MedComm 5 (1) (2024)
Wen-Hao Xu, Jiahe Lu, Xi Tian, Shiqi Ye, Shiyin Wei, Jun Wang, Aihetaimujiang Anwaier, Yuanyuan Qu, Wang-Rui Liu, Kun Chang, Hai-Liang Zhang, Dingwei Ye
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. MedComm 5 (1) (2024)
Wen-Hao Xu, Jianfeng Yang, Shiqi Ye, Wangrui Liu, Jiahe Lu, Aihetaimujiang Anwaier, Hai-Liang Zhang, Dingwei Ye
Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy. Immunotherapy 16 (3) (2023)
Hai-Liang Zhang, Lin Bai, Xin-Qiang Wu, Xi Tian, Jinwen Feng, Xiaohui Wu, Guo-Hai Shi, Xiaoru Pei, Jiacheng Lyu, Guojian Yang, Yang Liu, Wenhao Xu, Aihetaimujiang Anwaier, Yu Zhu, Da-Long Cao, Fu-Jiang Xu, Yue Wang, Hua-Lei Gan, Meng-Hong Sun, Jian-Yuan Zhao, Yuanyuan Qu, Dingwei Ye, Chen Ding
Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor. Nature communications 14 (1) (2023)
Wen-Hao Xu, Jianfeng Yang, Shiqi Ye, Wangrui Liu, Jiahe Lu, Aihetaimujiang Anwaier, Hai-Liang Zhang, Dingwei Ye
Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy. Immunotherapy 16 (3) (2023)
Wen-Hao Xu, Jianfeng Yang, Shiqi Ye, Wangrui Liu, Jiahe Lu, Aihetaimujiang Anwaier, Hai-Liang Zhang, Dingwei Ye
Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy. Immunotherapy (2023)
Yuanyuan Qu, Xiaohui Wu, Aihetaimujiang Anwaier, Jinwen Feng, Wenhao Xu, Xiaoru Pei, Yu Zhu, Yang Liu, Lin Bai, Guojian Yang, Xi Tian, Jiaqi Su, Guo-Hai Shi, Da-Long Cao, Fu-Jiang Xu, Yue Wang, Hua-Lei Gan, Shujuan Ni, Meng-Hong Sun, Jian-Yuan Zhao, Hai-Liang Zhang, Dingwei Ye, Chen Ding
Proteogenomic characterization of MiT family translocation renal cell carcinoma. Nature communications 13 (1) (2022)
Wei Han, Wen-Hao Xu, Jian-Xiong Wang, Jia-Min Hou, Hai-Liang Zhang, Xiao-Yu Zhao, Guo-Liang Shen
Identification, Validation, and Functional Annotations of Genome-Wide Profile Variation between Melanocytic Nevus and Malignant Melanoma. BioMed research international 2020 (2020)